Alphatec Spine to Showcase Product Portfolio at EuroSpine 2013 in Liverpool, UK
25 Septembre 2013 - 11:20PM
Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of
Alphatec Spine, Inc., a medical device company that provides
physician-inspired solutions for patients with spinal disorders,
announced today that it will showcase its product portfolio at the
upcoming EuroSpine 2013 meeting, which is being held in Liverpool,
UK, from October 2nd to 4th, 2013. Alphatec Spine will be located
in booth number A21. The EuroSpine annual meeting is an important
venue in Europe for sharing research, knowledge and innovation in
the prevention and treatment of spinal disorders.
This year Alphatec Spine will be showcasing key products from
all of its major portfolio segments including, MIS, Degenerative,
Deformity, Interbody, Cervical and Biologics. Products to be
focused on in Alphatec Spine's booth and workshop will include the
ILLICO® Multi-Level MIS system, the Alphatec Solus® ALIF cage, the
Epicage® MIS interbody device, and the Zodiac® DVR (Direct
Vertebral Rotation) Deformity system. Additionally, the Company
will also be highlighting several of its and Scient'x S.A.S.'s
products that have CE clearance, including the DiscoCerv®
artificial disc, the Isobar™ Evolution dynamic rod, the PCB
Evolution interbody device and the HeliFix® interspinous
process device, among others.
"We are excited to participate in EuroSpine 2013 and to discuss
the breadth of our product portfolio, while exchanging ideas and
best practices around key spinal topics that affect the lives of
the patients we serve," said Les Cross, Chairman and CEO of
Alphatec Spine, Inc. "Continuing to grow and support our
international business is a key component of our corporate
strategy. EuroSpine 2013 provides a forum where we can connect with
existing and potential international customers and demonstrate the
unique benefits and value of our complementary product suite. We
are proud to play a significant role in helping patients around the
world regain their active lifestyles."
In addition, on Friday, October 4th at 12:00pm in Room number
4A, Alphatec Spine will be hosting a workshop entitled, "Advanced
MIS and Open Techniques in Deformity Correction", featuring
presentations and facilitation by key thought leaders in spinal
surgery: Dr. Masood Shafafy, QMC Nottingham, UK and Dr. Robert Lee,
RNOH Stanmore, UK.
About Alphatec Spine
Alphatec Spine, Inc., a wholly owned subsidiary of Alphatec
Holdings, Inc., is a medical device company that designs, develops,
manufactures and markets physician-inspired products and solutions
for the treatment of spinal disorders associated with trauma,
congenital deformities, disease and degeneration. The Company's
mission is to combine innovative surgical solutions with
world-class customer service to improve outcomes and patient
quality of life. The Company and its affiliates market products in
the U.S. and in over 50 countries internationally via a direct
sales force and independent distributors.
Additional information can be found at
www.alphatecspine.com.
Forward Looking Statements
This press release may contain "forward-looking statements"
within the meaning of the Private Securities Litigation Reform Act
of 1995 that involve risks and uncertainty. Such statements are
based on management's current expectations and are subject to a
number of risks and uncertainties that could cause actual results
to differ materially from those described in the forward-looking
statements. Alphatec Spine cautions investors that there can be no
assurance that actual results or business conditions will not
differ materially from those projected or suggested in such
forward-looking statements as a result of various factors.
Forward-looking statements include references to the Company's
belief that certain of its products offer competitive
functionalities in the marketplace. The words "believe," "will,"
"should," "expect," "intend," "estimate" and "anticipate,"
variations of such words and similar expressions identify
forward-looking statements, but their absence does not mean that a
statement is not a forward-looking statement. The important
factors that could cause actual operating results to differ
significantly from those expressed or implied by such
forward-looking statements include, but are not limited to:
Alphatec Spine's ability to continue to grow and support its
international business; the uncertainty of success in developing or
acquiring and commercializing new products or product technologies;
acceptance of Alphatec Spine's and its affiliate's products by the
international surgeon community, including without limitation the
products discussed in this press release; Alphatec Spine's ability
to develop and expand its U.S. and/or global revenues; continuation
of favorable third part payor reimbursement for procedures
performed using Alphatec Spine's products; unanticipated expenses
or liabilities or other adverse events affecting cash flow or
Alphatec Spine's ability to successfully control its costs or
achieve profitability; uncertainty of additional funding; Alphatec
Spine's ability to compete with other competing products and with
emerging new technologies; product liability exposure; patent
infringement claims and claims related to Alphatec Spine's
intellectual property. Please refer to the risks detailed from time
to time in Alphatec Spine's SEC reports, including its Annual
Report Form 10-K, as well as other filings on Form 10-Q and
periodic filings on Form 8-K. Alphatec Spine disclaims any
intention or obligation to update or revise any forward-looking
statements, whether as a result of new information, future events,
or otherwise, unless required by law.
CONTACT: Investor/Media Contact:
Christine Zedelmayer
Investor Relations
Alphatec Spine, Inc.
(760) 494-6610
czedelmayer@alphatecspine.com
Alphatec (NASDAQ:ATEC)
Graphique Historique de l'Action
De Juil 2024 à Août 2024
Alphatec (NASDAQ:ATEC)
Graphique Historique de l'Action
De Août 2023 à Août 2024